Applied DNA Sciences Inc (APDN) Upgraded to Sell at ValuEngine
ValuEngine upgraded shares of Applied DNA Sciences Inc (OTCMKTS:APDN) from a strong sell rating to a sell rating in a research note published on Tuesday.
Separately, Maxim Group set a $5.00 price target on shares of Applied DNA Sciences and gave the company a buy rating in a research report on Friday, August 11th.
Applied DNA Sciences (OTCMKTS:APDN) opened at 3.28 on Tuesday. The company’s market capitalization is $89.80 million. Applied DNA Sciences has a 12-month low of $0.90 and a 12-month high of $3.37. The company’s 50 day moving average price is $2.32 and its 200-day moving average price is $1.74.
Applied DNA Sciences (OTCMKTS:APDN) last issued its earnings results on Thursday, August 10th. The technology company reported ($0.10) EPS for the quarter, beating analysts’ consensus estimates of ($0.14) by $0.04. Applied DNA Sciences had a negative return on equity of 121.00% and a negative net margin of 145.26%. The business had revenue of $1.80 million during the quarter, compared to analyst estimates of $2.18 million. During the same period in the previous year, the company posted ($0.14) EPS. The firm’s revenue was up 176.9% compared to the same quarter last year. Equities analysts forecast that Applied DNA Sciences will post ($0.44) earnings per share for the current fiscal year.
An institutional investor recently raised its position in Applied DNA Sciences stock. IHT Wealth Management LLC lifted its position in shares of Applied DNA Sciences Inc (OTCMKTS:APDN) by 13.9% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 9,106 shares of the technology company’s stock after purchasing an additional 1,110 shares during the period. IHT Wealth Management LLC’s holdings in Applied DNA Sciences were worth $100,000 at the end of the most recent quarter.
Applied DNA Sciences Company Profile
Applied DNA Sciences, Inc is engaged in creating security solutions addressing the challenges of modern commerce. The Company is also engaged in the large-scale production of specific deoxyribonucleic acid (DNA) sequences using the polymerase chain reaction (PCR). Its principal technology platform includes SigNature DNA, SigNature T DNA, fiberTyping, DNAnet, digitalDNA, SigNify and Beacon.
Receive News & Ratings for Applied DNA Sciences Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Applied DNA Sciences Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.